Isoray terminates Chief R&D Officer William Cavanagh III, expects separation agreement

Perspective Therapeutics, Inc.

William Cavanagh III terminated as Chief R&D Officer effective Feb 7, 2023; termination triggers his Employment Agreement change-of-control provisions.
Expected separation agreement: accrued wages at $341K annual salary, unreimbursed expenses (request within 5 days), plus one year health insurance premiums.
Separation agreement will include a release of all claims by Cavanagh against the company; no assurance it will be finalized.
Cavanagh remains subject to non-solicitation, non-disparagement, and confidentiality obligations post-termination.

item 1.02 item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

William Cavanagh III

Chief Research and Development Officer

CATX · Perspective Therapeutics, Inc.

Effective: 2023-02-07
Filed: February 10, 2023, 6:59 PM ET

William Cavanagh III was terminated from his position of Chief Research and Development Officer of the Company on February 7, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

William Cavanagh III was terminated as Chief Research and Development Officer at Perspective Therapeutics, Inc..

Action: terminated
Role: Chief Research and Development Officer

Exact text from the filing

William Cavanagh III was terminated from his position of Chief Research and Development Officer of the Company on February 7, 2023.

View on SEC.gov

Perspective Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-23-003047

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.